ArticleClinical orthopaedics and related research2018

Micrometastatic Drug Screening Platform Shows Heterogeneous Response to MAP Chemotherapy in Osteosarcoma Cell Lines.

Christopher D Collier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.